A message from Sarah Lyons, General Manager, Privacy Analytics
Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have the collective will, the personal urgency and the technical ability to make a meaningful difference in the fight against COVID-19.
That’s why Privacy Analytics has partnered with Vivli – an independent, non-profit organization that has developed a global data-sharing and analytics platform for sharing anonymized individual-patient level data. As announced during our April 2 webinar, we are part of a consortium working to accelerate the COVID-19 response through sharing of participant data from COVID-19 clinical trials via Vivli’s COVID-19 portal.
To ensure this global effort proceeds as expeditiously as possible, we have waived all fees to anonymize and share COVID-19 trial data. Vivli has also waived all fees to share, archive and access COVID-19 trials. Privacy Analytics will also waive fees to anonymize data from qualifying COVID-19 vaccine and pivotal drug trials.
We are committed to working with Vivli and doing our part to accelerate treatment for COVID-19. I am encouraged and inspired by the dedication and the devotion of our team, and by the speed with which the global healthcare community has rallied in this time of crisis.
To learn more about how to take part in accelerated COVID-19 data-sharing, please contact Michael McTaggart at email@example.com.